INSMED Inc
INSM· Nasdaq
INSMINSMED Inc
Filed Oct 30, 2025 · 10-Q · 30 days after period end · 0001104506-25-000053
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $142.34M | $93.43M | $79.07M | $67.73M |
| Net Income | -$370.02M | -$220.52M | -$158.93M | -$131.15M |
| EPS Diluted | -$1.75 | -$1.27 | -$1.11 | -$1.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Oct 30, 2025 · 30 d after period end
